🔗 Share this article

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, alleging the corporations hid safety concerns that the drug presented to pediatric cognitive development.

The court filing comes thirty days after Former President Trump publicized an unverified association between using acetaminophen - alternatively called paracetamol - during pregnancy and autism in offspring.

The attorney general is taking legal action against J&J, which formerly manufactured the medication, the exclusive pain medication approved for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he said they "misled consumers by gaining financially from discomfort and pushing pills without regard for the dangers."

Kenvue states there is no credible evidence tying Tylenol to autism.

"These manufacturers misled for generations, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, said.

The manufacturer commented that it was "very worried by the spread of false claims on the security of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its website, Kenvue also stated it had "continuously evaluated the relevant science and there is no credible data that indicates a established connection between using acetaminophen and autism."

Groups acting on behalf of medical professionals and healthcare providers agree.

The leading OB-GYN organization has said acetaminophen - the main ingredient in Tylenol - is a restricted selection for women during pregnancy to treat pain and elevated temperature, which can pose significant medical dangers if not addressed.

"In multiple decades of studies on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the usage of acetaminophen in any period of pregnancy causes neurodevelopmental disorders in young ones," the group stated.

The court filing mentions recent announcements from the Trump administration in asserting the medication is reportedly hazardous.

In recent weeks, the former president raised alarms from medical authorities when he advised women during pregnancy to "struggle intensely" not to consume Tylenol when unwell.

The US Food and Drug Administration then issued a notice that doctors should consider limiting the use of Tylenol, while also declaring that "a causal relationship" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary Kennedy, who manages the Food and Drug Administration, had pledged in April to conduct "a massive testing and research effort" that would identify the cause of autism in a limited time.

But specialists warned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the result of a intricate combination of inherited and external influences - would prove challenging.

Autism is a type of permanent neurological difference and condition that affects how individuals encounter and relate to the surroundings, and is identified using doctors' observations.

In his lawsuit, Paxton - who supports Trump who is seeking US Senate - asserts Kenvue and J&J "intentionally overlooked and attempted to silence the research" around acetaminophen and autism.

This legal action aims to force the corporations "destroy any marketing or advertising" that asserts Tylenol is secure for expectant mothers.

The Texas lawsuit mirrors the complaints of a assembly of guardians of minors with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in recently.

A federal judge threw out the legal action, saying studies from the family's specialists was not conclusive.